Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats

Journal of Ethnopharmacology

Volumn 131, Issue 1, 2010, Pages 88-94

  Cai, Yu ^a   Chen, JianWen ^b   Jiang, JianMin ^b   Cao, Weiwei ^b   He, Lan ^b  

^a UNIVERSITY OF JINAN   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Nephrin; Podocin; Podocyte; Proteinuria; Zhen wu tang

Indexed keywords

ANGIOTENSIN II; CHINESE DRUG; CREATININE; NEPHRIN; PODOCIN; UNCLASSIFIED DRUG; UREA; ZHEN WU TANG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; ELECTRON MICROSCOPY; KIDNEY INJURY; MALE; NONHUMAN; PODOCYTE; POLYURIA; PROTEIN EXPRESSION; PROTEINURIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; WEIGHT REDUCTION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; KIDNEY DISEASES; MALE; PROTEINURIA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 77955314144     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.06.004     Document Type: Article

References (44)

1. Aaltonen P., Luimula P., Astrom E., Palmen T., Grönholm T., Palojoki E., Jaakkola I., Ahola H., Tikkanen I., Holthofer H. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Laboratory Investigation 2001, 81:1185-1190.
2. Awad A.S., Huang L., Ye H., Duong E.T., Bolton W.K., Linden J., Okusa M.D. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. American Journal of Physiology: Renal Physiology 2006, 290:F828-F837.
3. Baelde H.J., Eikmans M., Lappin D.W., Doran P.P., Hohenadel D., Brinkkoetter P.T., van der Woude F.J., Waldherr R., Rabelink T.J., de Heer E., Bruijn J.A. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney International 2007, 71:637-645.
4. Blum S., Nakhoul F., Khankin E., Abassi Z. Renal slit diaphragm-the open zipper and the failing heart. The Israel Medical Association Journal 2007, 9:107-111.
5. Davis B., Dei Cas A., Long D.A., White K.E., Hayward A., Ku C.H., Woolf A.S., Bilous R., Viberti G., Gnudi L. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. Journal of the American Society Nephrology 2007, 18:2217-2218.
6. Doublier S., Salvidio G., Lupia E., Ruotsalainen V., Verzola D., Deferrari G., Camussi G. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003, 52:1023-1030.
7. Drumond M.C., Kristal B., Myers B.D., Deen W.M. Structural basis for reduced glomerular filtration capacity in nephrotic humans. The Journal of Clinical Investigation 1994, 94:1187-1195.
8. Fan Q., Ding J., Zhang J., Guan N., Deng J. Effect of the knockdown of podocin mRNA on nephrin and a-Actinin in mouse podocyte. Experimental Biology and Medicine 2004, 229:964-970.
9. Farid Nakhoul, Eliyahu Khankin, Afif Yaccob, Hiroshi Kawachi, Tony Karram, Huda Awaad, Nakhoul Nakhoul, Aaron Hoffman, Zaid Abassi Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. American Journal of Physiology Renal Physiology 2008, 294:628-637.
10. Gunter W., Sheldon C., Ziyadeh F.N. Podocyte injury comes of age in diabetic nephropathy. Diabetes 2005, 54:1626-1634.
11. He L., Rong X., Jiang J.M., Liu P.Q., Li Y. Amelioration of anti-cancer agent adriamycin-induced nephrotic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine. Food and Chemical Toxicology 2008, 46:1452-1460.
12. Huby A.C., Rastaldi M.P., Caron K., Smithies O., Dussaule J.C., Chatziantoniou C. Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS One 2009, 4:e6721.
13. Jefferson J.A., Shankland S.J., Pichler R.H. Proteinuria in diabetic kidney disease. Kidney International 2008, 74:22-36.
14. Kawachi H., Miyauchi N., Suzuki K., Han G.D., Orikasa M., Shimizu F. Role of podocyte slit diaphragm as a filtration barrier. Nephrology (Carlton) 2006, 11:274-281.
15. Kestila M., Lenkkeri U., Mannikko M., Lamerdin J., McCready P., Putaala H., Ruotsalainen V., Morita T., Nissinen M., Herva R., Kashtan C.E., Peltonen L., Holmberg C., Olsen A., Tryggvason K. Positionally cloned gene for a novel glomerular protein nephrin is mutated in congenital nephritic syndrome. Molecular Cell 1998, 1:575-582.
16. Koichi Suzuki, Gi Dong Han, Naoko Miyauchi, Taeko Hashimoto, Takeshi Nakatsue, Yumiko Fujioka, Hiroko Koike, Fujio Shimizu, Hiroshi Kawachi Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. The American Journal of Pathology 2007, 170:1841-1853.
17. Kurogi Y. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Medicinal Research Reviews 2003, 23:15-31.
18. Leese G.P., Savage M.W., Chattington P.D., Vora J.P. The diabetic patient with hypertension. Postgraduate Medical Journal 1996, 72:263-268.
19. Lenkkeri U., Mannikko M., McCready P., Lamerdin J., Gribouval O., Niaudet P.M., Antignac C.K., Kashtan C.E., Homberg C., Olsen A., Kestilä M., Tryggvason K. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. American Journal of Human Genetic 1999, 64:51-61.
20. Liang X.B., Ma L.J., Naito T., Wang Y., Madaio M., Zent R., Pozzi A., Fogo A.B. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. Journal of the American Society Nephrology 2006, 17:1886-1895.
21. Liebau M.C., Lang D., Bohm J., Endlich N., Bek M.J., Witherden I., Mathieson P.W., Saleem M.A., Pavenstadt H., Fischer K.G. Functional expression of the renin-angiotensin system in human podocytes. American Journal of Physiology: Renal Physiology 2006, 290:F710-F719.
22. Liu I.M., Tzeng T.F., Liou S.S., Chang C.J. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription. Journal of Ethnopharmacology 2009, 124:211-218.
23. Lopes A.A. End-stage renal disease due to diabetes in racial ethnic minorities and disadvantaged populations. Ethnicity & Disease 2009, 19. pp. S1-47-51.
24. Marshall Sally M. The Podocyte: a potential therapeutic target in diabetic nephropathy?. Current Pharmaceutical Design 2007, 13:2713-2720.
25. Menne J., Meier M., Park J.K., Boehne M., Kirsch T., Lindschau C., Ociepka R., Leitges M., Rinta-Valkama J., Holthofer H., Haller H. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney International 2006, 8:1456-1462.
26. Mima A., Matsubara T., Arai H., Abe H., Nagai K., Kanamori H., Sumi E., Takahashi T., Iehara N., Fukatsu A., Kita T., Doi T. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Laboratory Investigation 2006, 86:927-939.
27. Mogensen C.E., Keane W.F., Bennett P.H., Jerums G., Parving H.H., Passa P., Steffes M.W., Striker G.E., Viberti G.C. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995, 346:1080-1084.
28. Nyengaard J.R. Stereologic methods and their application in kidney. Journal of the American Society Nephrology 1999, 10:1100-1123.
29. Pagtalunan M.E., Rasch R., Rennke H.G., Meyer T.W. Morphometric analysis of effects of angiotensin II on glomerular structure in rats. The American Journal of Physiology 1995, 268:F82-F88.
30. Patari-Sampo A., Ihalmo P., Holthofer H. Molecular basis of the glomerular filtration: nephrin and the emerging protein complex at the podocyte slit diaphragm. Annals of Medicine 2006, 38:483-492.
31. Parving H.H. Diabetic nephropathy: prevention and treatment. Kidney International 2001, 60:2041-2055.
32. Pushparaj P.N., Low H.K., Manikandan J., Tan B.K., Tan C.H. Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 2007, 111:430-434.
33. Putaala H., Soininen R., Kilpelainen P., Wartiovaara J., Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Human Molecular Genetics 2001, 10:1-8.
34. Roselli S., Heidet L., Sich M., Henger A., Kretzler M., Gubler M.C., Antignac C. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Molecular and Cellular Biology 2004, 24:550-560.
35. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Current Diabetes Reports 2006, 6:479-483.
36. Schwarz K., Simons M., Reiser J., Saleem M.A., Faul C., Kriz W. Podocin, a raftassociated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. The Journal of Clinical Investigation 2001, 2108:1621-1629.
37. Shankland S.J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney International 2006, 69:2131-2147.
38. Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. Journal of the American Society Nephrology 1999, 10:2440-2445.
39. Van Damme B, Koudstaal J. Measuring glomerular diameters tissue sections. Virchows Archiv A: Pathological Anatomy and Histology 1976, 369:283-291.
40. Wada J., Makino H. Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists. Clinical and Experimental Nephrology 2009, 13:405-414.
41. Whaley-Connell A.T., Chowdhury N.A., Hayden M.R., Stump C.S., Habibi J., Wiedmeyer C.E., Gallagher P.E., Tallant E.A., Cooper S.A., Link C.D., Ferrario C., Sowers J.R. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. American Journal of Physiology: Renal Physiology 2006, 291:F1308-1314.
42. Wu Y., Dong J., Yuan L., Liang C., Ren K., Zhang W., Fang F., Shen J. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 2008, 44:85-91.
43. Xiong L., Li S. General situation of studies of Zhen-wu-tang Jiangxi. Journal of Traditional Chinese Medicine 2002, 33:43-45.
44. Zhang Z., Zhang Y., Ning G., Deb D.K., Kong J., Li Y.C. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proceedings of the National Academy Sciences of the United State of America 2008, 105:15896-15901.